Cantor Fitzgerald, L. P. Insmed Inc Transaction History
Cantor Fitzgerald, L. P.
- $4.65 Billion
- Q1 2025
A detailed history of Cantor Fitzgerald, L. P. transactions in Insmed Inc stock. As of the latest transaction made, Cantor Fitzgerald, L. P. holds 5,060 shares of INSM stock, worth $368,064. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,060
Previous 10,000
49.4%
Holding current value
$368,064
Previous $690,000
44.06%
% of portfolio
0.01%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding INSM
# of Institutions
489Shares Held
197MCall Options Held
892KPut Options Held
1.77M-
Vanguard Group Inc Valley Forge, PA18.3MShares$1.33 Billion0.03% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y915.4MShares$1.12 Billion81.63% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.04 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.9MShares$940 Million0.12% of portfolio
-
Capital International Investors Los Angeles, CA7.2MShares$524 Million0.11% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.85B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...